Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Perico
G Remuzzi

Showing results (241-250 of 551) with videos related to

Pageof 56
Sort By:
Kidney International. Supplement|April 29, 1998
Nitric oxide/endothelin balance after nephron reductionS Aiello, G Remuzzi, M Noris
Kidney International|January 1, 1997
Understanding the nature of renal disease progressionG Remuzzi, P Ruggenenti, A Benigni
Experimental Nephrology|November 13, 1999
Protein overload activates proximal tubular cells to release vasoactive and inflammatory mediatorsC Zoja, A Benigni, G Remuzzi
Kidney International|September 5, 2001
Thrombotic microangiopathy, hemolytic uremic syndrome, and thrombotic thrombocytopenic purpuraP Ruggenenti, M Noris, G Remuzzi
Annali Italiani Di Medicina Interna : Organo Ufficiale Della Societa Italiana Di Medicina Interna|October 1, 1993
[The role of endothelin in the progression of the renal disease in an experimental model of chronic kidney failure]S Orisio, C Zoja, G Remuzzi
Current Opinion in Nephrology and Hypertension|March 1, 1994
Treatment of idiopathic membranous glomerulopathyG Remuzzi, A Schieppati, S Garattini
Lancet (London, England)|April 16, 1994
Kidney/pancreas transplantationG Remuzzi, P Ruggenenti, M Mauer
Contributions to Nephrology|January 1, 1988
Low-protein diet prevents glomerular damage in experimental nephrosisC Zoja, A Remuzzi, G Remuzzi
British Journal of Obstetrics and Gynaecology|February 1, 1986
Recurrent abortion with lupus anticoagulant, and pre-eclampsia: a common final pathway for two different diseases? Case reportG Gregorini, G Setti, G Remuzzi
Drugs|June 12, 2001
Renoprotective therapy in patients with nondiabetic nephropathiesR Pisoni, P Ruggenenti, G Remuzzi
Pageof 56

Showing results (241-250 of 551) with videos related to

Sort By:
Pageof 56
Kidney International. Supplement|April 29, 1998
Nitric oxide/endothelin balance after nephron reductionS Aiello, G Remuzzi, M Noris
Kidney International|January 1, 1997
Understanding the nature of renal disease progressionG Remuzzi, P Ruggenenti, A Benigni
Experimental Nephrology|November 13, 1999
Protein overload activates proximal tubular cells to release vasoactive and inflammatory mediatorsC Zoja, A Benigni, G Remuzzi
Kidney International|September 5, 2001
Thrombotic microangiopathy, hemolytic uremic syndrome, and thrombotic thrombocytopenic purpuraP Ruggenenti, M Noris, G Remuzzi
Annali Italiani Di Medicina Interna : Organo Ufficiale Della Societa Italiana Di Medicina Interna|October 1, 1993
[The role of endothelin in the progression of the renal disease in an experimental model of chronic kidney failure]S Orisio, C Zoja, G Remuzzi
Current Opinion in Nephrology and Hypertension|March 1, 1994
Treatment of idiopathic membranous glomerulopathyG Remuzzi, A Schieppati, S Garattini
Lancet (London, England)|April 16, 1994
Kidney/pancreas transplantationG Remuzzi, P Ruggenenti, M Mauer
Contributions to Nephrology|January 1, 1988
Low-protein diet prevents glomerular damage in experimental nephrosisC Zoja, A Remuzzi, G Remuzzi
British Journal of Obstetrics and Gynaecology|February 1, 1986
Recurrent abortion with lupus anticoagulant, and pre-eclampsia: a common final pathway for two different diseases? Case reportG Gregorini, G Setti, G Remuzzi
Drugs|June 12, 2001
Renoprotective therapy in patients with nondiabetic nephropathiesR Pisoni, P Ruggenenti, G Remuzzi
Pageof 56